电邮这篇文章 Rapid HPLC-MS/MS Determination of Carbamazepine and Carbamazepine-10,11-Epoxide
- 作者: Rodina T.A.1,2, Mel’nikov E.S.3,2, Sokolov A.V.1,3, Prokof’ev A.B.1,3,2, Arkhipov V.V.1,3,2, Aksenov A.A.3, Pozdnyakov D.L.2
-
隶属关系:
- Federal Scientific Centre for Expert Evaluation of Medical Products, Ministry of Public Health of the Russian Federation
- I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health
- I. M. Sechenov First Moscow State Medical University
- 期: 卷 50, 编号 6 (2016)
- 页面: 419-423
- 栏目: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244408
- DOI: https://doi.org/10.1007/s11094-016-1462-6
- ID: 244408
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
A rapid HPLC-MS/MS method for simultaneous determination of carbamazepine and carbamazepine- 10,11-epoxide in human blood serum was developed. The analytical range for carbamazepine was 50 – 20,000 ng/mL; for carbamazepine-10,11-epoxide, 5 – 2,000 ng/mL. This allowed the developed method to be used for therapeutic drug monitoring, bioequivalence studies, and an assessment of the interchangeability of carbamazepine preparations.
作者简介
T. Rodina
Federal Scientific Centre for Expert Evaluation of Medical Products, Ministry of Public Health of the Russian Federation; I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health
Email: chem@folium.ru
俄罗斯联邦, Moscow, 127051; Moscow, 109240
E. Mel’nikov
I. M. Sechenov First Moscow State Medical University; I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health
Email: chem@folium.ru
俄罗斯联邦, Moscow, 119991; Moscow, 109240
A. Sokolov
Federal Scientific Centre for Expert Evaluation of Medical Products, Ministry of Public Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University
Email: chem@folium.ru
俄罗斯联邦, Moscow, 127051; Moscow, 119991
A. Prokof’ev
Federal Scientific Centre for Expert Evaluation of Medical Products, Ministry of Public Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University; I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health
Email: chem@folium.ru
俄罗斯联邦, Moscow, 127051; Moscow, 119991; Moscow, 109240
V. Arkhipov
Federal Scientific Centre for Expert Evaluation of Medical Products, Ministry of Public Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University; I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health
Email: chem@folium.ru
俄罗斯联邦, Moscow, 127051; Moscow, 119991; Moscow, 109240
A. Aksenov
I. M. Sechenov First Moscow State Medical University
Email: chem@folium.ru
俄罗斯联邦, Moscow, 119991
D. Pozdnyakov
I. V. Davydovsky Municipal Clinical Hospital, Moscow City Department of Health
Email: chem@folium.ru
俄罗斯联邦, Moscow, 109240
补充文件
